Inception Studio Capital

Inception Studio Capital is a Seed, Pre-Seed stage AI, Healthcare, Robotics, Biotech, SaaS investor, typically writing $100K – $1.5M checks, primarily investing in US. Their thesis: Experienced founders (particularly serial/exit founders) win 22x more often. Zero-equity retreats attract elite repeat founders who avoid traditional accelerators, enabling first-money positioning and best terms.

Inception Studio Capital typically writes $100K – $1.5M checks at the Seed, Pre-Seed stage in AI, Healthcare, Robotics, Biotech, SaaS.

Inception Studio Capital stands out on 4 points: Zero-equity model eliminates adverse selection and attracts founders avoiding traditional accelerators; 72-hour intensive retreats instead of multi-month programs, optimized for experienced founders; First-money positioning at formation ($100k starters) with follow-on allocation capacity ($500k-$1.5M); Founder-to-founder referral network (89% referral rate).

Funds with an overlapping stage and sector focus include Scribble Ventures, Uncork Capital, AngelPad.

Inception Studio Capital accepts cold inbound, so a warm introduction is not required.